The global market for Opioid-Induced Constipation (OIC) Treatment was valued at US$ 2765 million in the year 2024 and is projected to reach a revised size of US$ 3747 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Opioid-Induced Constipation (OIC) Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Opioid-Induced Constipation (OIC) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid-Induced Constipation (OIC) Treatment.

The Opioid-Induced Constipation (OIC) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid-Induced Constipation (OIC) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opioid-Induced Constipation (OIC) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Opioid-Induced Constipation (OIC) Treatment Market Report

Report Metric	Details
Report Name	Opioid-Induced Constipation (OIC) Treatment Market
Accounted market size in year	US$ 2765 million
Forecasted market size in 2031	US$ 3747 million
CAGR	4.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Parenteral (Subcutaneous Injection)
Segment by Application	Drug Store Independent Pharmacies Hospital Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, AstraZeneca, Pfizer, S.L.A. Pharma, AIKO Biotechnology, Cubist Pharmaceuticals, Salix Pharmaceuticals, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid-Induced Constipation (OIC) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Opioid-Induced Constipation (OIC) Treatment Market growing?

Ans: The Opioid-Induced Constipation (OIC) Treatment Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Opioid-Induced Constipation (OIC) Treatment Market size in 2031?

Ans: The Opioid-Induced Constipation (OIC) Treatment Market size in 2031 will be US$ 3747 million.

Who are the main players in the Opioid-Induced Constipation (OIC) Treatment Market report?

Ans: The main players in the Opioid-Induced Constipation (OIC) Treatment Market are GlaxoSmithKline, AstraZeneca, Pfizer, S.L.A. Pharma, AIKO Biotechnology, Cubist Pharmaceuticals, Salix Pharmaceuticals, Takeda Pharmaceutical

What are the Application segmentation covered in the Opioid-Induced Constipation (OIC) Treatment Market report?

Ans: The Applications covered in the Opioid-Induced Constipation (OIC) Treatment Market report are Drug Store, Independent Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the Opioid-Induced Constipation (OIC) Treatment Market report?

Ans: The Types covered in the Opioid-Induced Constipation (OIC) Treatment Market report are Oral, Parenteral (Subcutaneous Injection)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Parenteral (Subcutaneous Injection)

1.3 Market by Application

1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Drug Store

1.3.3 Independent Pharmacies

1.3.4 Hospital Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2020-2031)

2.2 Global Opioid-Induced Constipation (OIC) Treatment Growth Trends by Region

2.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Opioid-Induced Constipation (OIC) Treatment Market Dynamics

2.3.1 Opioid-Induced Constipation (OIC) Treatment Industry Trends

2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers

2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges

2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue

3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2020-2025)

3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue

3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio

3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2024

3.5 Global Key Players of Opioid-Induced Constipation (OIC) Treatment Head office and Area Served

3.6 Global Key Players of Opioid-Induced Constipation (OIC) Treatment, Product and Application

3.7 Global Key Players of Opioid-Induced Constipation (OIC) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type

4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2026-2031)

5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application

5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2020-2031)

6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025)

6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2020-2031)

7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025)

7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2020-2031)

9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025)

9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction

11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction

11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.2.5 AstraZeneca Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction

11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 S.L.A. Pharma

11.4.1 S.L.A. Pharma Company Details

11.4.2 S.L.A. Pharma Business Overview

11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction

11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.4.5 S.L.A. Pharma Recent Development

11.5 AIKO Biotechnology

11.5.1 AIKO Biotechnology Company Details

11.5.2 AIKO Biotechnology Business Overview

11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction

11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.5.5 AIKO Biotechnology Recent Development

11.6 Cubist Pharmaceuticals

11.6.1 Cubist Pharmaceuticals Company Details

11.6.2 Cubist Pharmaceuticals Business Overview

11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction

11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.6.5 Cubist Pharmaceuticals Recent Development

11.7 Salix Pharmaceuticals

11.7.1 Salix Pharmaceuticals Company Details

11.7.2 Salix Pharmaceuticals Business Overview

11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction

11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.7.5 Salix Pharmaceuticals Recent Development

11.8 Takeda Pharmaceutical

11.8.1 Takeda Pharmaceutical Company Details

11.8.2 Takeda Pharmaceutical Business Overview

11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction

11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

11.8.5 Takeda Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

S.L.A. Pharma

AIKO Biotechnology

Cubist Pharmaceuticals

Salix Pharmaceuticals

Takeda Pharmaceutical

GlaxoSmithKline

GlaxoSmithKline PLC

Astrazeneca plc

List of Tables

Table 1. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Parenteral (Subcutaneous Injection)

Table 4. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2020-2025)

Table 8. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2026-2031)

Table 10. Opioid-Induced Constipation (OIC) Treatment Market Trends

Table 11. Opioid-Induced Constipation (OIC) Treatment Market Drivers

Table 12. Opioid-Induced Constipation (OIC) Treatment Market Challenges

Table 13. Opioid-Induced Constipation (OIC) Treatment Market Restraints

Table 14. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players (2020-2025)

Table 16. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2024)

Table 17. Ranking of Global Top Opioid-Induced Constipation (OIC) Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Opioid-Induced Constipation (OIC) Treatment, Headquarters and Area Served

Table 20. Global Key Players of Opioid-Induced Constipation (OIC) Treatment, Product and Application

Table 21. Global Key Players of Opioid-Induced Constipation (OIC) Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. GlaxoSmithKline Company Details

Table 47. GlaxoSmithKline Business Overview

Table 48. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product

Table 49. GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 50. GlaxoSmithKline Recent Development

Table 51. AstraZeneca Company Details

Table 52. AstraZeneca Business Overview

Table 53. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product

Table 54. AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 55. AstraZeneca Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Opioid-Induced Constipation (OIC) Treatment Product

Table 59. Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. S.L.A. Pharma Company Details

Table 62. S.L.A. Pharma Business Overview

Table 63. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product

Table 64. S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 65. S.L.A. Pharma Recent Development

Table 66. AIKO Biotechnology Company Details

Table 67. AIKO Biotechnology Business Overview

Table 68. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product

Table 69. AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 70. AIKO Biotechnology Recent Development

Table 71. Cubist Pharmaceuticals Company Details

Table 72. Cubist Pharmaceuticals Business Overview

Table 73. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product

Table 74. Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 75. Cubist Pharmaceuticals Recent Development

Table 76. Salix Pharmaceuticals Company Details

Table 77. Salix Pharmaceuticals Business Overview

Table 78. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product

Table 79. Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 80. Salix Pharmaceuticals Recent Development

Table 81. Takeda Pharmaceutical Company Details

Table 82. Takeda Pharmaceutical Business Overview

Table 83. Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Product

Table 84. Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025) & (US$ Million)

Table 85. Takeda Pharmaceutical Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Opioid-Induced Constipation (OIC) Treatment Picture

Figure 2. Global Opioid-Induced Constipation (OIC) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Parenteral (Subcutaneous Injection) Features

Figure 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2024 VS 2031

Figure 8. Drug Store Case Studies

Figure 9. Independent Pharmacies Case Studies

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Opioid-Induced Constipation (OIC) Treatment Report Years Considered

Figure 12. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players in 2024

Figure 16. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue in 2024

Figure 18. North America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2020-2031)

Figure 20. United States Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2020-2031)

Figure 24. Germany Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2020-2031)

Figure 32. China Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 48. AstraZeneca Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 50. S.L.A. Pharma Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 51. AIKO Biotechnology Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 52. Cubist Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 53. Salix Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions